Serving hundreds of leading biopharmaceutical companies globally:

Generated: February 17, 2019

DrugPatentWatch Database Preview

OPDIVO Drug Profile

« Back to Dashboard

Summary for Tradename: OPDIVO

Patents:	55
Applicants:	1
BLAs:	2
Suppliers: see list	1
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for OPDIVO

Pharmacology for OPDIVO

Mechanism of Action	Programmed Death Receptor-1-directed Antibody Interactions

US Patents for OPDIVO

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Bristol Myers Squibb	OPDIVO	nivolumab	INJECTABLE;INJECTION	125527	001	2015-03-04	➤ Sign Up	Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC)	➤ Sign Up	RX		search
Bristol Myers Squibb	OPDIVO	nivolumab	INJECTABLE;INJECTION	125527	001	2015-03-04	➤ Sign Up	Oncomatryx Biopharma, S.L. (Derio, ES)	➤ Sign Up	RX		search
Bristol Myers Squibb	OPDIVO	nivolumab	INJECTABLE;INJECTION	125527	001	2015-03-04	➤ Sign Up	Biodesix, Inc. (Boulder, CO)	➤ Sign Up	RX		search
Bristol Myers Squibb	OPDIVO	nivolumab	INJECTABLE;INJECTION	125527	001	2015-03-04	➤ Sign Up	KANGPU BIOPHARMACEUTICALS, LTD. (Shanghai, CN)	➤ Sign Up	RX		search
Bristol Myers Squibb	OPDIVO	nivolumab	INJECTABLE;INJECTION	125527	001	2015-03-04	➤ Sign Up	Amgen Inc. (Thousand Oaks, CA)	➤ Sign Up	RX		search
Bristol Myers Squibb	OPDIVO	nivolumab	INJECTABLE;INJECTION	125527	001	2015-03-04	➤ Sign Up	Bristol-Myers Squibb Company (Princeton, NJ)	➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for OPDIVO

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Australia	2018250507	➤ Sign Up
Japan	2016520548	➤ Sign Up
Japan	5682000	➤ Sign Up
Canada	2841867	➤ Sign Up
Australia	2011207189	➤ Sign Up
Australia	2016285853	➤ Sign Up
Country	Document Number	Estimated Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice

Boehringer Ingelheim

Argus Health

Farmers Insurance

AstraZeneca

Harvard Business School

Cantor Fitzgerald

US Army

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.